AA
XLRN
ALPS Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-76,386
| Closed | -$8.6M | – | 896 |
|
|
2020
Q3 | $8.6M | Buy |
76,386
+2,965
| +4% | +$334K | 0.13% | 138 |
|
|
2020
Q2 | $7M | Sell |
73,421
-13,244
| -15% | -$1.26M | 0.09% | 135 |
|
|
2020
Q1 | $7.79M | Sell |
86,665
-20,193
| -19% | -$1.81M | 0.12% | 118 |
|
|
2019
Q4 | $5.67M | Buy |
106,858
+1,466
| +1% | +$77.7K | 0.04% | 150 |
|
|
2019
Q3 | $4.16M | Sell |
105,392
-4,440
| -4% | -$175K | 0.03% | 158 |
|
|
2019
Q2 | $4.51M | Sell |
109,832
-14,654
| -12% | -$602K | 0.03% | 161 |
|
|
2019
Q1 | $5.8M | Buy |
124,486
+17,744
| +17% | +$826K | 0.04% | 152 |
|
|
2018
Q4 | $4.65M | Buy |
106,742
+25,335
| +31% | +$1.1M | 0.04% | 157 |
|
|
2018
Q3 | $4.66M | Buy |
81,407
+14,975
| +23% | +$857K | 0.03% | 167 |
|
|
2018
Q2 | $3.22M | Buy |
66,432
+5,762
| +9% | +$280K | 0.02% | 197 |
|
|
2018
Q1 | $2.37M | Buy |
60,670
+10,545
| +21% | +$412K | 0.02% | 199 |
|
|
2017
Q4 | $2.13M | Buy |
50,125
+12,098
| +32% | +$513K | 0.01% | 193 |
|
|
2017
Q3 | $1.42M | Buy |
38,027
+3,174
| +9% | +$118K | 0.01% | 214 |
|
|
2017
Q2 | $1.06M | Buy |
34,853
+2,380
| +7% | +$72.3K | 0.01% | 226 |
|
|
2017
Q1 | $860K | Sell |
32,473
-3,801
| -10% | -$101K | 0.01% | 230 |
|
|
2016
Q4 | $926K | Sell |
36,274
-11,656
| -24% | -$298K | 0.01% | 225 |
|
|
2016
Q3 | $1.74M | Sell |
47,930
-4,357
| -8% | -$158K | 0.01% | 192 |
|
|
2016
Q2 | $1.78M | Buy |
52,287
+10,569
| +25% | +$359K | 0.02% | 177 |
|
|
2016
Q1 | $1.1M | Sell |
41,718
-2,087
| -5% | -$55.1K | 0.01% | 185 |
|
|
2015
Q4 | $2.14M | Sell |
43,805
-7,942
| -15% | -$387K | 0.02% | 172 |
|
|
2015
Q3 | $12.9K | Buy |
51,747
+19,188
| +59% | +$4.78K | 0.01% | 200 |
|
|
2015
Q2 | $1.03M | Buy |
32,559
+16,486
| +103% | +$522K | 0.01% | 213 |
|
|
2015
Q1 | $612K | Buy |
+16,073
| New | +$612K | 0.01% | 212 |
|